# Comprehensive Enhancement Framework for MCT Digital Therapeutic Product Specification

## Executive Summary

This specification defines a **Metacognitive Therapy (MCT) Digital Therapeutic** product designed to deliver a structured 8-10 week program for reducing the Cognitive Attentional Syndrome (CAS) and modifying maladaptive metacognitive beliefs. The product emphasizes **process over content**, focusing exclusively on HOW users relate to their thoughts rather than WHAT they think about.

### Core Product Principles

1. **Process-focused intervention**: No content analysis, reassurance, or problem-solving
2. **Measurable behavioral change**: Quantifiable reductions in worry/rumination time and belief modifications
3. **Low-burden daily practice**: ≤20 minutes total daily engagement
4. **Evidence-based protocols**: Strict adherence to Wells' MCT model
5. **Single-user local deployment**: Privacy-first, no cloud dependencies

### Target Outcomes

- **≥20-30% reduction** in average daily worry minutes by Week 4-8
- **≥15-20 point reduction** in uncontrollability belief (0-100 scale) by Week 4-8
- **≥10-20% reduction** in checking/reassurance frequency by Week 5-8
- **Consistent skill practice**: median ATT ≥50 min/week by Week 2; DM ≥7 practices/week

## Product Architecture Overview

```
┌─────────────────────────────────────────────────────────┐
│                    MCT Digital Therapeutic                │
├───────────────┬─────────────┬──────────────┬────────────┤
│  Onboarding   │   Daily     │    Weekly    │  Progress  │
│  & Assessment │   Practice  │   Modules    │  Tracking  │
├───────────────┼─────────────┼──────────────┼────────────┤
│ • Case Form   │ • ATT       │ • Psychoed   │ • CAS Logs │
│ • Beliefs     │ • DM        │ • Experiments│ • Beliefs  │
│ • Goals       │ • Postpon.  │ • Reviews    │ • Streaks  │
│ • Schedule    │ • SAR       │ • Unlocks    │ • Insights │
└───────────────┴─────────────┴──────────────┴────────────┘
```

## Module Structure

### Module 0: [Orientation and Strategic Positioning](./product-spec/modules/module-0-orientation.md)
- Product value proposition
- Clinical adoption pathways
- Core MCT principles
- Success metrics

### Module 1: [Clinical Model and Fidelity](./product-spec/modules/module-1-clinical.md)
- S-REF model implementation
- CAS quantification
- Metacognitive belief tracking
- Fidelity requirements

### Module 2: [Program Architecture and User Journeys](./product-spec/modules/module-2-architecture.md)
- 8-10 week program structure
- Daily routine specifications
- User flow optimization
- Engagement patterns

### Module 3: [Weekly Content Modules](./product-spec/modules/module-3-weekly-content.md)
- Week-by-week curriculum
- Learning objectives
- Script templates
- Experiment designs

### Module 4: [Exercise Library](./product-spec/modules/module-4-exercises.md)
- ATT specifications
- DM protocols
- SAR builder
- Postponement mechanics

### Module 5: [Behavioral Experiments](./product-spec/modules/module-5-experiments.md)
- 12 core experiment templates
- Belief-targeted interventions
- Measurement protocols
- Learning capture

### Module 6: [Measurement and Outcomes](./product-spec/modules/module-6-measurement.md)
- Daily/weekly metrics
- Process-focused psychometrics
- Outcome thresholds
- Data collection protocols

### Module 7: [Progress Visualization](./product-spec/modules/module-7-visualization.md)
- Dashboard specifications
- Insight generation
- Trend analysis
- Motivational feedback

### Module 8: [Personalization and Pacing](./product-spec/modules/module-8-personalization.md)
- Adaptation rules
- Practice pattern recognition
- Content customization
- Pacing adjustments

### Module 9: [Engagement and Habit Formation](./product-spec/modules/module-9-engagement.md)
- Notification strategies
- Streak mechanics
- Commitment devices
- MCT-safe gamification

## Clinical Governance

### Fidelity Checklist
- [ ] All content is process-focused (no content analysis)
- [ ] No reassurance mechanisms
- [ ] Quantifiable metrics for all interventions
- [ ] Clear crisis routing pathways
- [ ] Weekly belief re-rating protocols
- [ ] Experiment-based learning capture

### Safety Rails
- Immediate routing to crisis services for acute risk indicators
- Exclusion criteria clearly stated (psychosis, active substance use, severe depression)
- No diagnostic claims or treatment promises
- Process-only focus prevents iatrogenic content fixation

## Implementation Priorities

### Phase 1: Core MCT Delivery (Weeks 1-8)
- Complete onboarding flow
- Daily practice tools (ATT, DM, logging)
- Basic progress tracking
- Weekly module unlocks

### Phase 2: Enhanced Measurement (Weeks 9-16)
- Advanced analytics
- Personalization rules
- Experiment library expansion
- Outcome reporting

### Phase 3: Clinical Integration (Weeks 17-24)
- Clinician dashboard
- Export capabilities
- Integration APIs
- Regulatory preparation

## Success Metrics

### User Engagement
- **Activation**: ≥70% complete onboarding Day 1
- **Retention**: ≥40% complete 4+ days Week 1; ≥25% reach Week 4
- **Practice**: Median ATT ≥50 min/week; DM ≥7/week by Week 2

### Clinical Outcomes
- **CAS Reduction**: ≥20% decrease in worry/rumination minutes
- **Belief Change**: ≥15-point reduction in negative metacognitive beliefs
- **Skill Acquisition**: Demonstrated time-to-refocus improvement

### Product Quality
- **Usability**: Onboarding ≤7 minutes
- **Daily Burden**: Total practice ≤20 minutes
- **Fidelity**: 100% content passes MCT checklist

## Appendices

- [A. Clinical References](./product-spec/clinical/references.md)
- [B. Content Scripts](./product-spec/content/scripts.md)
- [C. Measurement Instruments](./product-spec/measurement/instruments.md)
- [D. Acceptance Criteria](./product-spec/acceptance/criteria.md)

---

*This specification serves as the authoritative guide for MCT Digital Therapeutic development. All implementation decisions must align with these clinical and product requirements.*